Published in Cardiovasc Diabetol on April 15, 2015
Serum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart Failure. PLoS One (2015) 0.79
Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort study. Cardiovasc Diabetol (2016) 0.77
Association between Maternal Serum Concentrations of Angiopoietin-like Protein 2 in Early Pregnancy and Subsequent Risk of Gestational Diabetes Mellitus. Chin Med J (Engl) (2016) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Inflammation and metabolic disorders. Nature (2006) 33.33
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999) 16.30
Vascular-specific growth factors and blood vessel formation. Nature (2000) 14.42
Elevated C-reactive protein levels in overweight and obese adults. JAMA (1999) 9.94
Mechanisms linking obesity with cardiovascular disease. Nature (2006) 9.07
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J (2008) 4.74
Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care (1999) 3.01
Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract (2004) 2.95
The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med (2008) 2.14
Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab (2009) 2.13
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care (1999) 2.01
Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 1.97
Obesity and metabolic syndrome in Korea. Diabetes Metab J (2011) 1.86
Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature (2012) 1.75
Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem (1999) 1.69
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol (2005) 1.67
The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol (2006) 1.42
Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases. FEBS J (2010) 1.35
Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2012) 1.22
Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform? Mayo Clin Proc (2010) 1.14
Angiopoietin-like proteins: a comprehensive look. Front Endocrinol (Lausanne) (2014) 1.12
Chemokine systems link obesity to insulin resistance. Diabetes Metab J (2013) 1.09
Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol (2014) 1.03
Angiopoietin-like protein 2 and risk of type 2 diabetes in a general Japanese population: the Hisayama study. Diabetes Care (2012) 1.01
Angiopoietin-like proteins--potential therapeutic targets for metabolic syndrome and cardiovascular disease. Circ J (2009) 0.99
Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends Endocrinol Metab (2014) 0.98
Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury. J Mol Cell Cardiol (2013) 0.96
Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological properties. Expert Rev Mol Med (2014) 0.93
Angiopoietin-like 2 promotes atherogenesis in mice. J Am Heart Assoc (2013) 0.93
Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocr J (2012) 0.91
Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes. Endocrinology (2011) 0.91
Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy. Mediators Inflamm (2012) 0.91
Association of serum C1q/TNF-related protein-9 concentration with arterial stiffness in subjects with type 2 diabetes. J Clin Endocrinol Metab (2014) 0.88
Angiopoietin-like protein 2 sensitively responds to weight reduction induced by lifestyle intervention on overweight Japanese men. Nutr Diabetes (2011) 0.83
Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: In vitro and in vivo evidence. Exp Ther Med (2013) 0.82
Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study. Circ J (2013) 0.81
Low-renin (volume dependent) mild-hypertensive patients have impaired flow-mediated and glyceryl-trinitrate stimulated vascular reactivity. Circ J (2005) 0.80
Use of carotid ultrasound to stratify risk. Can J Cardiol (2001) 0.79
Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes. Diabetes Res Clin Pract (2013) 0.79